Go Pro
NASDAQ:ATEC

Alphatec (ATEC) Stock Price, News & Analysis

Alphatec logo
$9.49 +0.18 (+1.93%)
As of 04:00 PM Eastern

About Alphatec Stock (NASDAQ:ATEC)

Advanced

Key Stats

Today's Range
$9.10
$9.52
50-Day Range
$7.48
$10.35
52-Week Range
$6.82
$23.29
Volume
1.97 million shs
Average Volume
2.47 million shs
Market Capitalization
$1.47 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.40
Consensus Rating
Moderate Buy

Company Overview

Alphatec Holdings, Inc. (NASDAQ: ATEC) is a medical technology company focused on the design, development and commercialization of products for the surgical correction of degenerative spinal conditions. The company’s portfolio centers on interbody implants, biologics, fixation devices and surgical planning tools intended to improve patient outcomes in spinal fusion procedures. Alphatec’s flagship offerings include customizable interbody cages, bone graft materials and specialized instrumentation designed for minimally invasive and open spinal surgeries.

Founded as Alphatec Spine in 1985 and rebranded as Alphatec Holdings in 2018, the company has grown from a single-product organization into a multi-platform innovator in the spine market. Alphatec has introduced technologies such as the iGAINS® implant for adjustable anatomical fit and the SONICanchor® fixation system to enhance implant stability. Its proprietary OsteoStrand™ biologic portfolio supports bone growth through versatile carrier options, reflecting the company’s emphasis on combining mechanical and biological approaches to fusion.

Alphatec serves a broad patient base across North America, with expanding footprints in Europe, Latin America and select Asia-Pacific markets. The company collaborates with hospitals, ambulatory surgery centers and specialty spine centers, providing training and support services to surgeons adopting its technologies. Regional distribution agreements and direct sales channels aim to ensure consistent product availability and clinical support worldwide.

Under the leadership of President and Chief Executive Officer William J. Dickerson, Alphatec has pursued strategic partnerships and targeted acquisitions to diversify its technology pipeline. The senior management team brings experience in medical device commercialization, regulatory affairs and global operations. With ongoing investments in research and development, Alphatec continues to advance its next-generation systems and digital planning tools to address evolving surgical needs in spine care.

AI Generated. May Contain Errors.

Alphatec Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
80th Percentile Overall Score

ATEC MarketRank™: 

Alphatec scored higher than 80% of companies evaluated by MarketBeat, and ranked 123rd out of 903 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Alphatec has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on no strong buy ratings, 13 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Alphatec has a consensus price target of $17.40, representing about 83.4% upside from its current price of $9.49.

  • Amount of Analyst Coverage

    Alphatec has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Alphatec's stock forecast and price target.
  • Earnings Growth

    Earnings for Alphatec are expected to grow in the coming year, from ($0.44) to $0.05 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Alphatec is -13.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Alphatec is -13.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Alphatec has a P/B Ratio of 118.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Alphatec's valuation and earnings.
  • Percentage of Shares Shorted

    10.33% of the float of Alphatec has been sold short.
  • Short Interest Ratio / Days to Cover

    Alphatec has a short interest ratio ("days to cover") of 5.73.
  • Change versus previous month

    Short interest in Alphatec has recently decreased by 5.94%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Alphatec does not currently pay a dividend.

  • Dividend Growth

    Alphatec does not have a long track record of dividend growth.

  • News Sentiment

    Alphatec has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Alphatec this week, compared to 6 articles on an average week.
  • Search Interest

    9 people have searched for ATEC on MarketBeat in the last 30 days. This is an increase of 80% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Alphatec to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Alphatec insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $127,282.00 in company stock.

  • Percentage Held by Insiders

    13.48% of the stock of Alphatec is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    66.35% of the stock of Alphatec is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Alphatec's insider trading history.
Receive ATEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATEC Stock News Headlines

Lake Street Sticks to Their Buy Rating for Alphatec Holdings (ATEC)
Alphatec Holdings (ATEC) Receives a Buy from Wells Fargo
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
Alphatec: Straightening Its Back
See More Headlines

ATEC Stock Analysis - Frequently Asked Questions

Alphatec's stock was trading at $21.04 at the beginning of the year. Since then, ATEC stock has decreased by 54.9% and is now trading at $9.49.

Alphatec Holdings, Inc. (NASDAQ:ATEC) announced its quarterly earnings results on Tuesday, August, 4th. The medical technology company reported $0.07 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.07. The firm's revenue for the quarter was up 15.1% on a year-over-year basis.
Read the conference call transcript
.

Top institutional shareholders of Alphatec include Bank of New York Mellon Corp (0.23%), Great Lakes Advisors LLC (0.18%), Assenagon Asset Management S.A. (0.10%) and Handelsbanken Fonder AB (0.03%). Insiders that own company stock include Squadron Capital Llc, Jennifer N Pritzker, David R Pelizzon, Patrick Miles, Craig E Hunsaker, Scott Lish, Tyson Eliot Marshall, Mortimer Berkowitz III, David Sponsel, David M Demski, John Todd Koning, Jeffrey P Rydin, Karen K Mcginnis, David H Mowry and Evan Bakst.
View institutional ownership trends
.

Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alphatec investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD) and Meta Platforms (META).

Company Calendar

Last Earnings
8/04/2026
Today
8/10/2026
Next Earnings (Estimated)
10/29/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:ATEC
CIK
1350653
Employees
700
Year Founded
1990

Price Target and Rating

High Price Target
$25.00
Low Price Target
$12.00
Potential Upside/Downside
+83.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
15 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.71)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$143.36 million
Net Margins
-13.49%
Pretax Margin
-13.46%
Return on Equity
-6,752.24%
Return on Assets
-13.88%

Debt

Debt-to-Equity Ratio
40.35
Current Ratio
1.89
Quick Ratio
1.07

Sales & Book Value

Annual Sales
$764.16 million
Price / Sales
1.92
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.08 per share
Price / Book
118.63

Miscellaneous

Outstanding Shares
154,450,000
Free Float
133,631,000
Market Cap
$1.47 billion
Optionable
Optionable
Beta
0.85

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:ATEC) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners